Mutations
MAPT T427M
Quick Links
Overview
Pathogenicity: Frontotemporal Dementia : Uncertain Significance, Parkinson's Disease : Not Classified
Clinical
Phenotype: Frontotemporal Dementia, Parkinson's Disease
Position: (GRCh38/hg38):Chr17:46024125 C>T
Position: (GRCh37/hg19):Chr17:44101491 C>T
dbSNP ID: rs63750991
Coding/Non-Coding: Coding
DNA
Change: Substitution
Expected RNA
Consequence: Substitution
Expected Protein
Consequence: Missense
Codon
Change: ACG to ATG
Reference
Isoform: Tau Isoform Tau-F (441 aa)
Genomic
Region: Exon 13
Findings
The T427M mutation was first described in an Italian patient with a family history of dementia and clinical features typical of frontotemporal dementia. Starting at age 60 she developed language disturbance and personality changes with apathy. Although her cognition was affected later in the course of the disease, her memory and spatial skills were relatively spared. The patient died at age 67 and no autopsy was performed. The mutation was absent in the proband's two unaffected sisters (ages 64 and 53), as well as in 150 control individuals and 150 other people with dementia (Giaccone et al., 2005).
This variant was later detected in one out of 188 cases with Parkinson’s disease (Schulte et al., 2015). This individual had apparently idiopathic PD; however, family history information was not available. This individual developed symptoms at age 66, starting with resting tremor. Later symptoms included bradykinesia, rigor, and postural instability. Dementia was not present. This variant was absent in 188 cases of PD with dementia and in 376 elderly controls. Note that this study reported the variant as T762M in reference to tau isoform G (P10636-9), aka isoform 6 (NP_001116538), which is 776 amino acids long. It is numbered here as T427M to reflect its position in tau isoform F (P10636-8), which is 441 amino acids in length and conventionally used for describing mutations in MAPT.
Neuropathology
Unknown. MRI showed moderate frontotemporal atrophy, more prominent on the left (Giaccone et al., 2005).
Biological Effect
Unknown.
Last Updated: 18 Jul 2024
References
Paper Citations
- Giaccone G, Rossi G, Farina L, Marcon G, Di Fede G, Catania M, Morbin M, Sacco L, Bugiani O, Tagliavini F. Familial frontotemporal dementia associated with the novel MAPT mutation T427M. J Neurol. 2005 Dec;252(12):1543-5. Epub 2005 Jun 6 PubMed.
- Schulte EC, Fukumori A, Mollenhauer B, Hor H, Arzberger T, Perneczky R, Kurz A, Diehl-Schmid J, Hüll M, Lichtner P, Eckstein G, Zimprich A, Haubenberger D, Pirker W, Brücke T, Bereznai B, Molnar MJ, Lorenzo-Betancor O, Pastor P, Peters A, Gieger C, Estivill X, Meitinger T, Kretzschmar HA, Trenkwalder C, Haass C, Winkelmann J. Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease. Eur J Hum Genet. 2015 Jan 21; PubMed.
External Citations
Further Reading
No Available Further Reading
Protein Diagram
Primary Papers
- Giaccone G, Rossi G, Farina L, Marcon G, Di Fede G, Catania M, Morbin M, Sacco L, Bugiani O, Tagliavini F. Familial frontotemporal dementia associated with the novel MAPT mutation T427M. J Neurol. 2005 Dec;252(12):1543-5. Epub 2005 Jun 6 PubMed.
Alzpedia
Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.